Chandra Bhagat Pharma Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Chandra Bhagat Pharma Ltd with 125 companies shown from the same industry classification, including Murae Organisor Ltd, Bacil Pharma Ltd, Gujarat Terce Laboratories Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.60/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 39.5 Cr. | 27.5 | 61.8/10.6 | 60.7 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 30.4 Cr. | 39.0 | 59.8/29.0 | 13.7 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Vivimed Labs Ltd | 48.7 Cr. | 5.55 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Bharat Immunological & Biological Corporation Ltd | 49.0 Cr. | 11.4 | 22.6/11.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Mangalam Drugs and Organics Ltd | 49.6 Cr. | 31.4 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 51.3 Cr. | 31.5 | 46.8/25.6 | 107 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| ANG Lifesciences India Ltd | 53.6 Cr. | 41.1 | 49.7/17.6 | 47.6 | 0.00 % | 0.95 % | 7.33 % | 10.0 | |
| Checkpoint Trends Ltd | 18.0 Cr. | 32.9 | 144/28.4 | 14.6 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Cian Healthcare Ltd | 57.7 Cr. | 23.1 | 23.1/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 12.1 Cr. | 23.9 | 27.6/15.9 | 19.6 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 12.0 Cr. | 4.57 | 25.0/3.90 | 4.57 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.6 Cr. | 77.4 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Colinz Laboratories Ltd | 9.41 Cr. | 74.7 | 87.9/36.1 | 18.8 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 6.42 Cr. | 21.4 | 24.4/17.7 | 7.55 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.06 Cr. | 6.00 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.35 Cr. | 0.81 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.81 Cr. | 1.53 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Fervent Synergies Ltd | 76.4 Cr. | 15.3 | 26.0/13.0 | 21.0 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Denis Chem Lab Ltd | 95.4 Cr. | 68.7 | 97.4/56.1 | 12.0 | 66.0 | 3.64 % | 14.0 % | 9.52 % | 10.0 |
| Concord Drugs Ltd | 104 Cr. | 78.6 | 92.5/61.0 | 50.7 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 105 Cr. | 29.8 | 66.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Vaishali Pharma Ltd | 109 Cr. | 8.39 | 11.9/4.75 | 25.8 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Krebs Biochemicals & Industries Ltd | 124 Cr. | 56.4 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 125 Cr. | 59.8 | 99.8/46.0 | 28.6 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Lactose (India) Ltd | 134 Cr. | 106 | 136/76.0 | 19.3 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 137 Cr. | 9.35 | 14.3/1.96 | 45.7 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 138 Cr. | 126 | 135/69.7 | 35.4 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Auro Laboratories Ltd | 147 Cr. | 235 | 317/159 | 30.6 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 151 Cr. | 6.24 | 10.0/4.70 | 471 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Par Drugs & Chemicals Ltd | 154 Cr. | 125 | 180/78.0 | 10.6 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Brooks Laboratories Ltd | 166 Cr. | 56.5 | 139/36.3 | 12.6 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Bal Pharma Ltd | 179 Cr. | 112 | 125/59.7 | 24.8 | 51.6 | 1.07 % | 9.69 % | 7.87 % | 10.0 |
| Coral Laboratories Ltd | 195 Cr. | 546 | 679/360 | 10.3 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 207 Cr. | 10.7 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Everest Organics Ltd | 215 Cr. | 216 | 536/197 | 40.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Gennex Laboratories Ltd | 242 Cr. | 9.98 | 17.2/7.05 | 12.9 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| BDH Industries Ltd | 292 Cr. | 507 | 610/340 | 24.9 | 134 | 0.99 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 298 Cr. | 82.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Aarey Drugs & Pharmaceuticals Ltd | 310 Cr. | 99.9 | 104/50.3 | 74.2 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Albert David Ltd | 499 Cr. | 876 | 932/580 | 22.1 | 686 | 0.57 % | 0.82 % | 0.44 % | 10.0 |
| Kilitch Drugs (India) Ltd | 747 Cr. | 217 | 234/117 | 24.8 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Wanbury Ltd | 760 Cr. | 217 | 360/162 | 17.7 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 847 Cr. | 364 | 370/94.8 | 109 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Anuh Pharma Ltd | 898 Cr. | 89.5 | 99.5/66.7 | 20.3 | 35.1 | 1.68 % | 14.9 % | 10.7 % | 5.00 |
| Themis Medicare Ltd | 1,103 Cr. | 120 | 147/65.0 | 43.3 | 0.42 % | 2.74 % | 0.41 % | 1.00 | |
| Lincoln Pharmaceuticals Ltd | 1,170 Cr. | 584 | 770/440 | 12.1 | 378 | 0.31 % | 16.3 % | 12.3 % | 10.0 |
| Kopran Ltd | 1,399 Cr. | 291 | 294/107 | 56.0 | 110 | 1.03 % | 6.65 % | 4.91 % | 10.0 |
| Fermenta Biotech Ltd | 1,411 Cr. | 479 | 580/249 | 25.8 | 138 | 0.78 % | 20.6 % | 16.4 % | 5.00 |
| TTK Healthcare Ltd | 1,460 Cr. | 1,034 | 1,250/735 | 19.1 | 789 | 0.97 % | 8.04 % | 6.30 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,465 Cr. | 505 | 760/476 | 23.6 | 128 | 0.97 % | 24.8 % | 18.4 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,552 Cr. | 235 | 265/155 | 33.0 | 41.2 | 1.70 % | 22.7 % | 17.3 % | 2.00 |
| Hester Biosciences Ltd | 1,848 Cr. | 2,165 | 2,684/1,239 | 34.8 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Venus Remedies Ltd | 2,284 Cr. | 1,711 | 2,044/424 | 19.7 | 497 | 0.58 % | 20.7 % | 15.6 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 2,287 Cr. | 1,387 | 1,600/427 | 51.4 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Beta Drugs Ltd | 2,289 Cr. | 2,065 | 2,808/990 | 50.2 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Panacea Biotec Ltd | 2,290 Cr. | 375 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Syncom Formulations (India) Ltd | 2,461 Cr. | 26.2 | 26.6/10.2 | 29.0 | 4.39 | 0.38 % | 24.8 % | 17.6 % | 1.00 |
| Indoco Remedies Ltd | 2,484 Cr. | 269 | 317/162 | 102 | 0.07 % | 0.96 % | 9.36 % | 2.00 | |
| Dishman Carbogen Amcis Ltd | 2,528 Cr. | 161 | 307/128 | 139 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Hikal Ltd | 2,682 Cr. | 218 | 261/146 | 63.2 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,152 Cr. | 282 | 420/252 | 20.0 | 146 | 1.90 % | 14.0 % | 10.2 % | 2.00 |
| Ind-Swift Laboratories Ltd | 3,591 Cr. | 413 | 420/87.0 | 55.2 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,635 Cr. | 750 | 774/422 | 851 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Kwality Pharmaceuticals Ltd | 3,758 Cr. | 3,625 | 3,949/829 | 46.0 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Aarti Drugs Limited | 3,917 Cr. | 429 | 534/319 | 22.6 | 154 | 0.47 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,997 Cr. | 568 | 687/278 | 32.7 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Gufic BioSciences Ltd | 4,368 Cr. | 436 | 468/268 | 59.4 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| SMS Pharmaceuticals Ltd | 4,494 Cr. | 479 | 494/240 | 49.6 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Zota Health Care Ltd | 4,503 Cr. | 1,300 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| RPG Life Sciences Ltd | 5,113 Cr. | 3,089 | 3,130/1,731 | 43.8 | 366 | 0.78 % | 25.7 % | 19.3 % | 8.00 |
| Gujarat Themis Biosyn Ltd | 5,170 Cr. | 398 | 479/225 | 106 | 26.4 | 0.17 % | 18.1 % | 17.4 % | 1.00 |
| FDC Ltd | 5,712 Cr. | 350 | 476/313 | 18.6 | 153 | 1.43 % | 15.4 % | 11.2 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,911 Cr. | 201 | 219/67.1 | 33.5 | 61.3 | 0.50 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 6,077 Cr. | 1,015 | 1,144/471 | 336 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| Morepen Laboratories Ltd | 6,516 Cr. | 119 | 127/33.0 | 55.5 | 22.8 | 0.17 % | 8.05 % | 5.33 % | 2.00 |
| Sanofi India Ltd | 7,076 Cr. | 3,072 | 4,898/3,049 | 20.6 | 359 | 2.44 % | 57.5 % | 43.0 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,560 Cr. | 711 | 745/118 | 54.9 | 113 | 0.21 % | 16.9 % | 11.8 % | 1.00 |
| Entero Healthcare Solutions Ltd | 7,789 Cr. | 1,790 | 1,920/944 | 60.4 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Aarti Pharmalabs Ltd | 8,821 Cr. | 973 | 985/584 | 41.0 | 234 | 0.36 % | 10.7 % | 8.59 % | 5.00 |
| Suven Life Sciences Ltd | 9,171 Cr. | 325 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Procter & Gamble Health Ltd | 9,444 Cr. | 5,696 | 6,975/4,700 | 28.3 | 316 | 2.72 % | 83.9 % | 61.9 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,551 Cr. | 557 | 693/325 | 44.9 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Concord Biotech Ltd | 14,564 Cr. | 1,393 | 1,668/987 | 51.2 | 193 | 0.54 % | 17.4 % | 12.6 % | 1.00 |
| Natco Pharma Ltd | 15,109 Cr. | 843 | 1,227/789 | 13.2 | 515 | 0.59 % | 17.4 % | 17.1 % | 2.00 |
| Marksans Pharma Ltd | 15,530 Cr. | 343 | 351/155 | 30.0 | 66.7 | 0.26 % | 18.8 % | 15.2 % | 1.00 |
| Astrazeneca Pharma India Ltd | 15,618 Cr. | 6,254 | 9,850/6,196 | 90.0 | 349 | 0.58 % | 29.3 % | 23.3 % | 2.00 |
| Jubilant Pharmova Ltd | 16,748 Cr. | 1,048 | 1,185/784 | 43.2 | 445 | 0.48 % | 8.99 % | 6.53 % | 1.00 |
| ERIS Lifesciences Ltd | 16,920 Cr. | 1,219 | 1,740/1,180 | 25.8 | 282 | 0.59 % | 14.1 % | 18.7 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,937 Cr. | 862 | 998/635 | 22.7 | 289 | 1.39 % | 12.6 % | 13.4 % | 2.00 |
| Cohance Lifesciences Ltd | 17,496 Cr. | 458 | 918/267 | 162 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,902 Cr. | 3,913 | 5,578/3,887 | 23.3 | 919 | 1.92 % | 24.1 % | 18.0 % | 10.0 |
| Shilpa Medicare Ltd | 20,690 Cr. | 1,056 | 1,076/260 | 72.8 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Caplin Point Laboratories Ltd | 20,867 Cr. | 2,744 | 2,991/1,500 | 31.4 | 443 | 0.29 % | 24.2 % | 20.9 % | 2.00 |
| Granules India Ltd | 23,706 Cr. | 867 | 924/511 | 36.5 | 205 | 0.20 % | 15.5 % | 13.8 % | 1.00 |
| Acutaas Chemicals Ltd | 26,321 Cr. | 3,214 | 3,740/1,290 | 68.2 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Neuland Laboratories Ltd | 27,433 Cr. | 21,375 | 24,235/11,500 | 55.1 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Wockhardt Ltd | 35,661 Cr. | 2,194 | 2,422/1,087 | 89.4 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 44,386 Cr. | 3,558 | 3,797/2,330 | 39.1 | 362 | 0.90 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 47,136 Cr. | 2,784 | 3,121/2,088 | 44.8 | 134 | 2.05 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 49,151 Cr. | 1,938 | 2,039/1,252 | 35.8 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 49,342 Cr. | 2,990 | 3,042/1,574 | 34.9 | 656 | 0.67 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 57,908 Cr. | 27,270 | 30,655/25,135 | 35.9 | 2,247 | 1.93 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 61,423 Cr. | 377 | 447/337 | 84.5 | 210 | 0.13 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 62,843 Cr. | 5,250 | 5,934/5,051 | 27.6 | 1,156 | 1.01 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Life Sciences Ltd | 65,554 Cr. | 2,326 | 2,538/1,793 | 21.0 | 372 | 0.21 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 68,601 Cr. | 2,442 | 2,538/1,793 | 22.0 | 372 | 0.20 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 93,847 Cr. | 2,052 | 2,530/1,900 | 15.8 | 491 | 0.88 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 97,710 Cr. | 1,698 | 1,740/1,066 | 25.8 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 1,00,579 Cr. | 2,436 | 2,642/1,910 | 44.5 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,365 Cr. | 1,252 | 1,415/1,080 | 32.4 | 454 | 0.64 % | 13.0 % | 11.2 % | 1.00 |
| Laurus Labs Ltd | 1,06,859 Cr. | 1,979 | 2,055/827 | 122 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,11,012 Cr. | 1,379 | 1,673/1,166 | 31.0 | 426 | 0.94 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,86,137 Cr. | 4,894 | 5,250/3,480 | 83.4 | 248 | 0.78 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,893.91 Cr | 1,269.72 | 56.15 | 211.60 | 0.38% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Chandra Bhagat Pharma Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Chandra Bhagat Pharma Ltd analysis · Explore all Pharmaceuticals stocks